Focused programs in tumor metabolism, precision delivery, nucleic acid therapeutics and immuno-oncology — built on dual R&D platforms and GLP/cGMP facilities.
Attenuated Salmonella (PhoP/PhoQ mutant) engineered to deliver shSTAT3/shPD-L1 gene therapy directly into the tumor microenvironment — natural tumor enrichment exceeding 1,000× normal tissue.
mRNA drugs targeting oncogenic drivers (RAS, P53, MDM2, cMYC, STAT3) for major solid tumors.
mRNA cancer vaccines addressing lung, liver and colorectal cancer antigens.
Our programs translate platform capabilities into disciplined drug development candidates.
shSTAT3/shPD-L1 gene therapy for colorectal cancer — a single drug simultaneously targeting STAT3 ("de-malignancy") and PD-L1 ("immune enhancement"). Preclinical tumor growth inhibition of 6.7%–94.2% across multiple human tumor lines; 70% cure rate with no recurrence over two years in a mouse H22 orthotopic liver cancer model; favorable large-animal safety profile.
Umbilical cord mesenchymal stem cell (hUC-MSC) therapy for tuberculous destroyed lung. IIT clinical study (Phase I/IIa) with Shenzhen Third People's Hospital, combining anti-inflammatory, anti-fibrotic, immunomodulatory and lung-repair mechanisms to address an unmet need affecting more than 200,000 patients in China.
mRNA therapeutics targeting RAS, P53, MDM2, cMYC and STAT3 — addressing high-unmet-need oncogenic drivers in major solid tumors.
Therapeutic mRNA cancer vaccines for lung, liver and colorectal cancer.
Stem cell regenerative repair technology for bone and orthopedic injuries (autologous bone-marrow MSC therapy).
Biotech R&D and manufacturing laboratories meeting GLP and cGMP standards at our Shenzhen R&D base support drug development, cell preparation and technical services.
Stem cell prep roomsImmune cell prep roomsSeed cell prep roomsPositive control prep roomsPCR testing laboratoryMicrobiology laboratoryPhysicochemical laboratory-196°C liquid nitrogen storage
Ion Proton SequencerOptima XPN-100 UltracentrifugeStepOnePlus qPCRBioanalyzer 2100Milli-Q Water SystemFluorescence MicroscopyFlow CytometryCO₂ IncubatorsLive Cell WorkstationControlled-Rate Freezer
Peer-reviewed research supporting our platform technologies will be featured here as they become available.
Details of upcoming scientific conference presentations and investor events will be posted here.